INVEST-HD - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington's Disease
Principal Investigator
Burton L. Scott, MD, PhD
Neurologist
Protocol Number
IRB:
PRO00119676
NCT:
NCT07326709
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment